openPR Logo
Press release

The companion diagnostics (CDx) market is projected to grow with a good CAGR during the forecast period 2018-2023

The companion diagnostics (CDx) market is projected to grow with

The recent study on the companion diagnostics market covers an in-depth analysis of the market on the basis of technology, indication, and geography. The report also covers the country level analysis within the regions as well. In addition, the report covers the key trends in the market along with drivers and restraints during the forecast period 2018-2023. According to the report titled “Companion Diagnostics (CDx) Market - Forecasts From 2018 TO 2023”, the market is expected to surge at a substantial annual growth rate during the projected period. The report has segmented the CDx market by technology (Polymerase Chain Reaction, Immunohistochemistry, In-situ Hybridization, Next Generation Sequencing), indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Other Oncology, non-oncology diseases), geography (North America, South America, Europe, Middle East and Africa, Asia Pacific). The companion diagnostics find use in identification of patients who are most likely to be benefitted from a therapeutic product, identification of patients who are likely to be at an increased risk of getting serious side effects and monitoring treatment response of a therapeutic product in order to achieve safety and efficacy of the treatment. The market is currently at a nascent stage but is poised to show strong growth during the forecast period owing to help companies in identifying the need of the companion drugs in the drug development process in addition to growing research and development activities. The growing trend of personalized medicine and the growing incidences of cancer will further boost the growth of the global CDx market. Furthermore, rising healthcare expenditure, technological advancements, and growing pharmaceutical industry are also driving the market growth.

Request Sample: www.knowledge-sourcing.com/requestsample&sample_id=1983

Growing incidences of cancer worldwide is one of the significant contributors in driving the market growth during the forecast period and beyond.

According to the Cancer Research UK, the worldwide cancer incidence statistics state that there are 17 million new cases of cancer in 2018, the new cases of cancer comprises of more than 4 out of ten cases which are as follows: lung cancer, female breast, bowel, or prostate cancer. In addition, the worldwide cancer incidence rates are projected to increase by more than 62% by 2030.

Companion diagnostics are being utilized in view of the evolving cancer care where the researchers are devoting huge resources in the development of companion diagnostics in order to provide targeted therapies to improve the survival rates in patients suffering from cancer. Many oncologists and cancer care professionals have recognized that some cancer drugs are more effective among individuals with specific tumor molecular characteristics, thus, calling for the need of companion diagnostics, which may be more critical as the cancers are being increasingly subdivided on the basis of their molecular characteristics.

North America is expected to hold the largest market share.

The North America companion diagnostics market is expected to hold a major market share during the forecast period. This is due to the technological advancements in the companion diagnostics, high healthcare expenditure by the United States, early adoption of innovation, and a high level of awareness among the people regarding companion diagnostics. In addition, many key market players are based in this region, thus are collaborating with each other regarding the research and development activities in companion diagnostics. Furthermore, companies are also collaborating with each other in order to expand the global reach and delivery of companion diagnostics in the region.

Some of the major players discussed in the reports are Abbott Laboratories, Agilent Technologies, Inc., and F. Hoffmann-La Roche Ltd., among others.

Request customization or place an order: www.knowledge-sourcing.com/companion-diagnostics-cdx-market

About Us:
Knowledge Sourcing Intelligence (KSI) is a market research and consulting organization based out of India. KSI publishes research studies spanning across ten industry verticals. KSI has a team of experienced and young professionals with a singular focus on delivering high-quality research services to enterprises, non-government organizations, government agencies, and research institutes and organizations. We publish hundreds of reports per year centering on niche and latest technologies. We engage with key decision makers and stakeholders across the value chain to provide clients with a detailed analysis and bird’s-eye view of the market with whole market dynamics, statistical forecasts, competitive analysis, key trends, market drivers and challenges and strategic recommendations for making informed decisions. Our success lies in the effort of our analysts who strive to meet client expectations by delivering quality work within the stipulated deadlines.

Contact:
Knowledge Sourcing Intelligence LLP
2nd Floor, D-77, Sector 63
Noida, U.P. - 201301
India
E: sales@knowledge-sourcing.com | P: +1-866-714-4587

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The companion diagnostics (CDx) market is projected to grow with a good CAGR during the forecast period 2018-2023 here

News-ID: 1620655 • Views: 292

More Releases from Knowledge Sourcing Intelligence LLP

Automotive Intercoolers Market is Estimated to Reach a Value of US$21.878 Billio …
Knowledge Sourcing Intelligence announces the publication of a new report on “Automotive Intercooler Market - Forecasts from 2020 to 2025" to their offering. Automotive Intercoolers are mechanical devices used for cooling the air after it is compressed. The main purpose of the intercooler is to act as a heat exchanger for removing heat from the compressor. They find use in A.Cs and automotive engines. Many individuals among the general population are
Halal Food Market is projected to grow at a CAGR of 5.94% to reach US$2,047.163 …
Knowledge Sourcing Intelligence announces the publication of a new report on “Halal Food Market - Forecasts from 2020 to 2025" to their offering. The shifting consumer preferences towards the consumption of halal food due to diverse tastes among the Muslim population around the globe is anticipated to be a key factor bolstering the market growth in the coming years. The halal food market is projected to show decent growth during the
Global Case Packers Market is estimated to surge at a CAGR of 4.68% from 2018-20 …
Knowledge Sourcing Intelligence announces the publication of a new report on “Case Packers Market - Forecasts from 2019 to 2024" to their offering. The case packer industry is predicted to grow in spite of the novel coronavirus global outbreak due to the growing need for essential items which include grocery, and necessary medical supplies in bulk to the healthcare organizations, retail shops, or directly to the consumers. The case packer market
The Medical Electronics Market is projected to grow at a CAGR of 6.21% by 2025
Knowledge Sourcing Intelligence announces the publication of a new report on “Medical Electronics Market - Forecasts from 2020 to 2025" to their offering. Continuous advancements in technologies like the Internet of Things (IoT), Artificial Intelligence (AI), and Virtual Reality (VR) among many others have been fuelling their uptake across all major industries. Huge investments by many healthcare providers into advanced equipment and machinery have been increasing the adoption of medical

All 5 Releases


More Releases for CDx

Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Mark …
This report studies the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market by companies, region, type and end-use industry. Get Sample Copy of This Report @ https://www.researchtrades.com/request-sample/1644663 In 2017, the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market size was million US$ and it is expected to reach million US$ by the end of 2025,
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market 2018 …
The Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market 2018 to 2025 renders deep perception of the key regional market status of the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Industry on a global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan. The report on “Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market” is a professional report
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Sale …
This report studies the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market, analyzes and researches the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Qiagen NV GE Healthcare Agilent Technologies F Hoffman La Roche Foundation Medicine Thermo Fisher Scientific Inc. Leica Biosystems Nussloch GmBH Pfizer Get the sample copy of report : https://www.marketresearchreports.biz/sample/sample/1486733 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast
Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Mark …
Qyresearchreports include new market research report "Global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size,Status and Forecast 2025" to its huge collection of research reports. The report on the global Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market covers all major factors such as growth drivers, leading segments, market size estimates, and technological advancements for the 2018-2025 forecast period. These factors hold significance for a qualitative and quantitative analysis of the Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market
Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market Size …
This report provides in depth study of “Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. The Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) Market report also provides an in-depth survey of key players in the market which is based on the various objectives of an organization such as profiling, the product outline, the quantity of production, required raw material, and the financial health of
Companion Diagnostics (CDx) Market size is expected to reach US$ 5.0 Billion by …
The global companion diagnostics (CDx) market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period 2016 to 2024 Companion diagnostic (CDx) is a diagnostic tool used to determine the suitability of a drug therapy to the patient. It has become a critical part of targeted cancer therapy that allows for development of personalized therapy can be developed and